ABELZETA Trademark

Trademark Overview


On Monday, July 24, 2023, a trademark application was filed for ABELZETA with the United States Patent and Trademark Office. The USPTO has given the ABELZETA trademark a serial number of 98098345. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, July 15, 2024. This trademark is owned by CELLULAR BIOMEDICINE GROUP, INC.. The ABELZETA trademark is filed in the Chemical Products, Pharmaceutical Products, Treatment & Processing of Materials Services, Education & Entertainment Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Educational services, namely, the presentation of lectures and panel discussions in the field of medicine

Custom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use

Pharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; viral vectors and plasmids for clinical use; cells for medical use

Excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; viral vectors and plasmids for scientific research

Cell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer, autoimmune, and inflammatory diseases; medical diagnostic services
abelzeta

General Information


Serial Number98098345
Word MarkABELZETA
Filing DateMonday, July 24, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 7, 2024

Trademark Statements


Goods and ServicesEducational services, namely, the presentation of lectures and panel discussions in the field of medicine
Goods and ServicesCustom manufacturing of biological tissue, blood, and cells; custom manufacturing of pharmaceutical preparations for immunotherapy; custom manufacture of pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of cancer and autoimmune diseases; custom manufacture of viral vectors and plasmids for research and clinical use; custom manufacture of excipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use
Description of MarkThe mark consists of the stylized word "ABELZETA" where "ABEL" is dark grey in color and "ZETA" is maroon in color.
Goods and ServicesPharmaceutical and biological preparations for medical use, namely, for the treatment and prevention of diseases, namely, cancer and autoimmune diseases; pharmaceutical preparations, namely, pharmaceutical preparations for use in the treatment of cancer; pharmaceutical and biological preparations for immunotherapy; pharmaceutical and biological preparations for medical diagnostic use; diagnostic kits consisting primarily of cells for medical or clinical use; viral vectors and plasmids for clinical use; cells for medical use
Indication of Colors claimedThe colors dark grey and maroon are claimed as a feature of the mark.
Goods and ServicesExcipients for use in the manufacture of pharmaceutical and biological preparations for research and medical use; viral vectors and plasmids for scientific research
Goods and ServicesCell therapy services, namely, immune cell therapy services and medical treatment using cultured cells; Collection and preservation of biological tissue, blood and cells; providing medical information; providing health information in the field of oncology; providing medical information in the field of pharmaceuticals and cell therapy; medical treatment services, namely, medical treatment of cancer, autoimmune, and inflammatory diseases; medical diagnostic services

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, August 22, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameABELZETA INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850

Party NameABELZETA INC.
Party Type11 - New Owner Before Publication
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850

Party NameCELLULAR BIOMEDICINE GROUP, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressROCKVILLE, MD 20850

Trademark Events


Event DateEvent Description
Tuesday, August 22, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, July 27, 2023NEW APPLICATION ENTERED
Wednesday, August 23, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Monday, August 28, 2023TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, December 27, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, January 19, 2024ASSIGNED TO LIE
Friday, January 19, 2024PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Tuesday, March 26, 2024ASSIGNED TO EXAMINER
Friday, March 29, 2024EXAMINERS AMENDMENT -WRITTEN
Friday, March 29, 2024EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, March 29, 2024EXAMINER'S AMENDMENT ENTERED
Friday, March 29, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 7, 2024PUBLISHED FOR OPPOSITION
Wednesday, April 17, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 7, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 15, 2024SOU TEAS EXTENSION RECEIVED
Monday, July 15, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2024SOU EXTENSION 1 GRANTED
Monday, July 15, 2024SOU EXTENSION 1 FILED